Literature DB >> 18777992

A comparison of the nicotine lozenge and nicotine gum: an effectiveness randomized controlled trial.

Quinn R Pack1, Douglas E Jorenby, Michael C Fiore, Thomas Jackson, Patricia Weston, Megan E Piper, Timothy B Baker.   

Abstract

CONTEXT: Both the nicotine gum and nicotine lozenge have been shown to increase smoking cessation rates, but no published trials have directly compared the two. Higher dose nicotine gum has been recommended as a treatment that may reduce cessation-related weight gain. DESIGN/OUTCOME: In a diverse urban setting, 408 participants were randomized to receive either the lozenge or the gum for 8 weeks of treatment. Seven-day point prevalence of smoking abstinence was biochemically confirmed by exhaled carbon monoxide levels of less than 10 ppm measured at 8 weeks with follow-up at 6 and 12 months.
RESULTS: At 8 weeks, the lozenge quit rate was 15.1% and the gum quit rate was 11.3%, with an odds ratio of 1.39, 95% confidence interval (0.78-2.49) P=0.26. These rates compare favorably to a historical spontaneous quit rate of 5%. Quit rate comparisons were similarly non-significant at 6 and 12 months. At 8 weeks, successful quitters in the lozenge group gained 3.0+/-6.3 lbs compared to the gum group, which gained 8.4+/-9.2 lbs with t=-2.4, P=0.02, but this finding was not sustained at 6 and 12 months.
CONCLUSIONS: The gum and lozenge appear equally effective for smoking cessation; however, for patients concerned about preventing cessation related to immediate weight gain, the lozenge may be the better agent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777992      PMCID: PMC3174063     

Source DB:  PubMed          Journal:  WMJ        ISSN: 1098-1861


  19 in total

1.  Efficacy of a nicotine lozenge for smoking cessation.

Authors:  Saul Shiffman; Carolyn M Dresler; Peter Hajek; Simon J A Gilburt; Darren A Targett; Kenneth R Strahs
Journal:  Arch Intern Med       Date:  2002-06-10

2.  Hardening and the hard-core smoker: concepts, evidence, and implications.

Authors:  Kenneth E Warner; David M Burns
Journal:  Nicotine Tob Res       Date:  2003-02       Impact factor: 4.244

Review 3.  Self-administered treatment for smoking cessation.

Authors:  Susan J Curry; Evette J Ludman; Jennifer McClure
Journal:  J Clin Psychol       Date:  2003-03

4.  Comment on Shiffman and colleagues, "Nicotine patch and lozenge are effective for women".

Authors:  Kenneth A Perkins; John Scott
Journal:  Nicotine Tob Res       Date:  2005-12       Impact factor: 4.244

5.  Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-07-01       Impact factor: 17.586

6.  Tobacco use among adults--United States, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-10-27       Impact factor: 17.586

7.  Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study.

Authors:  Howard S Marsh; Carolyn M Dresler; Jae H Choi; Darren A Targett; Michael L Gamble; Kenneth R Strahs
Journal:  Clin Ther       Date:  2005-10       Impact factor: 3.393

8.  Smoking cessation with and without assistance: a population-based analysis.

Authors:  S Zhu; T Melcer; J Sun; B Rosbrook; J P Pierce
Journal:  Am J Prev Med       Date:  2000-05       Impact factor: 5.043

9.  Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis.

Authors:  Marcus Munafò; Mike Bradburn; Lucy Bowes; Sean David
Journal:  Nicotine Tob Res       Date:  2004-10       Impact factor: 4.244

10.  Influence of training dose on nicotine discrimination in humans.

Authors:  K A Perkins; D D'Amico; M Sanders; J E Grobe; A Wilson; R L Stiller
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

View more
  7 in total

1.  Patient Perception of How Smoking Status Influences Cardiac Rehabilitation Attendance After an Acute Cardiac Hospitalization.

Authors:  Hayden Riley; Samuel Headley; Peter K Lindenauer; Sarah Goff; Heidi Szalai; Diann E Gaalema; Quinn R Pack
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-05       Impact factor: 2.081

Review 2.  Interventions for preventing weight gain after smoking cessation.

Authors:  Jamie Hartmann-Boyce; Annika Theodoulou; Amanda Farley; Peter Hajek; Deborah Lycett; Laura L Jones; Laura Kudlek; Laura Heath; Anisa Hajizadeh; Marika Schenkels; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2021-10-06

3.  Planning a Change Easily (PACE): A randomized controlled trial for smokers who are not ready to quit.

Authors:  Francisco I Salgado García; Karen J Derefinko; Zoran Bursac; Sarah Hand; Robert C Klesges
Journal:  Contemp Clin Trials       Date:  2018-03-13       Impact factor: 2.226

4.  Weight gain in smokers after quitting cigarettes: meta-analysis.

Authors:  Henri-Jean Aubin; Amanda Farley; Deborah Lycett; Pierre Lahmek; Paul Aveyard
Journal:  BMJ       Date:  2012-07-10

5.  Pharmacokinetic characterization of three novel 4-mg nicotine lozenges
.

Authors:  Manpreet Sukhija; Reena Srivastava; Aditya Kaushik
Journal:  Int J Clin Pharmacol Ther       Date:  2018-03       Impact factor: 1.366

6.  Single-Dose Bioequivalence of Two Mini Nicotine Lozenge Formulations.

Authors:  Scott C Rasmussen; William D Becker; Gilbert M Shanga
Journal:  Clin Pharmacol Drug Dev       Date:  2017-11-28

7.  Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers.

Authors:  Scott Rasmussen; Kathleen Halabuk Horkan; Mitchell Kotler
Journal:  Clin Pharmacol Drug Dev       Date:  2018-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.